1 |
Zhu X, Yang Y, Gao W, Jiang B, Shi L. Capparis spinosa Alleviates DSS-Induced Ulcerative Colitis via Regulation of the Gut Microbiota and Oxidative Stress. Evid Based Complement Alternat Med 2021;2021:1227876. [PMID: 34956375 DOI: 10.1155/2021/1227876] [Reference Citation Analysis]
|
2 |
Hu Y, Ye Z, She Y, Li L, Wu M, Qin K, Li Y, He H, Hu Z, Yang M, Lu F, Ye Q. Efficacy and Safety of Probiotics Combined With Traditional Chinese Medicine for Ulcerative Colitis: A Systematic Review and Meta-Analysis. Front Pharmacol 2022;13:844961. [DOI: 10.3389/fphar.2022.844961] [Reference Citation Analysis]
|
3 |
Wei Y, Ren S, Wang R, Jing M, Liu H, Wang M, Song H, Zhao Y. Based on Network Pharmacology to Explore the Potential Bioactive Compounds and Mechanisms of Zuojin Pill for the Treatment of Ulcerative Colitis. Evid Based Complement Alternat Med 2021;2021:7567025. [PMID: 34484403 DOI: 10.1155/2021/7567025] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
4 |
Wang W, Xu C, Li X, Wang Z, Yang J, Shen Y, Shi M, Chen L, Zhang L, Guo Y, Wang B, Zhang T, Pu Y. Exploration of the potential mechanism of Banxia Xiexin Decoction for the effects on TNBS-induced ulcerative colitis rats with the assistance of network pharmacology analysis. J Ethnopharmacol 2021;277:114197. [PMID: 34004261 DOI: 10.1016/j.jep.2021.114197] [Reference Citation Analysis]
|
5 |
Yen H, Hsu Y, Kuo C, Hsu T, Chen Y. Real‐world experience of adalimumab therapy for patients with ulcerative colitis: A single tertiary medical center experience in Central Taiwan. Adv in Digestive Medicine. [DOI: 10.1002/aid2.13300] [Reference Citation Analysis]
|